Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 5/2024

06-02-2024 | Hematuria | ASO Author Reflections

ASO Author Reflections: Clinical Stage I Clear Cell Renal Cell Carcinoma Patients with Gross Hematuria: Radical Nephrectomy or Partial Nephrectomy?

Authors: Zhuo Xing, MD, Yuan Li, MD

Published in: Annals of Surgical Oncology | Issue 5/2024

Login to get access

Excerpt

Clear cell renal cell carcinoma (ccRCC) is a common histologic subtype of renal cell carcinoma, and the selection of nephrectomy types for patients with ccRCC depends largely on the tumor stage. Most RCCs have been discovered accidentally through noninvasive radiographic examinations. According to the current radiographic examination method, the ability to predict T3a disease accurately before surgery still is very limited. It is not uncommon for patients to upgrade from stage T1 to T3a after surgery.1,2 …
Literature
1.
2.
3.
Metadata
Title
ASO Author Reflections: Clinical Stage I Clear Cell Renal Cell Carcinoma Patients with Gross Hematuria: Radical Nephrectomy or Partial Nephrectomy?
Authors
Zhuo Xing, MD
Yuan Li, MD
Publication date
06-02-2024
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 5/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-024-14988-5

Other articles of this Issue 5/2024

Annals of Surgical Oncology 5/2024 Go to the issue

ASO Author Reflections

ASO Author Reflections: Using a CA19-9 Tumor Marker Gene Test to Assess Outcome after Pancreatic Cancer Surgery

Thoracic Oncology

Comment on “Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study”

Translational Research

BRAF V600E Mutation Lacks Association with Poorer Clinical Prognosis in Papillary Thyroid Carcinoma

ASO Author Reflections

ASO Author Reflections: Accuracy and Prognostic Impact of Nodal Status on Preoperative Imaging for Management of Pancreatic Neuroendocrine Tumors

ASO Perspectives

At the Speed of SOUND: The Pace of Change for Axillary Management in Breast Cancer

Breast Oncology

A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 Years with ER+ Breast Cancer